NASDAQ: NVAXNovavax Inc Stock Ownership - Who owns Novavax?
Insider buying vs selling
Have Novavax Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Trizzino | President and COO | 2024-03-10 | 2,226 | $5.45 | $12.13kSell |
| James Patrick Kelly | EVP CFO and Treasurer | 2024-03-10 | 2,226 | $5.45 | $12.13kSell |
| Filip Dubovsky | President RD | 2024-03-10 | 2,597 | $5.45 | $14.15kSell |
| Filip Dubovsky | President RD | 2024-03-07 | 9,392 | $5.61 | $52.69kSell |
| James Patrick Kelly | EVP CFO and Treasurer | 2024-03-07 | 5,905 | $5.61 | $33.13kSell |
| John Trizzino | EVP CCO and CBO | 2024-03-07 | 13,955 | $5.61 | $78.29kSell |
| Elaine Ohara | EVP Chief Strategy Officer | 2024-03-01 | 19,600 | $5.39 | $105.64kBuy |
| Elaine Ohara | EVP Chief Strategy Officer | 2024-03-01 | 5,375 | $5.39 | $28.97kSell |
| John C. Jacobs | President and CEO | 2024-01-23 | 40,093 | $4.26 | $170.80kSell |
| John A. Herrmann Iii | EVP Chief Legal Officer | 2023-12-14 | 700 | $5.69 | $3.98kSell |
NVAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NVAX insiders and whales buy or sell their stock.
NVAX Shareholders
What type of owners hold Novavax Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| State Street Corp | 11.99% | 16,775,875 | $69.62M | Institution |
| Vanguard Group Inc | 10.40% | 14,560,061 | $60.42M | Institution |
| Cadila Pharmaceuticals Ltd | 6.79% | 9,500,000 | $39.43M | Insider |
| Blackrock Inc | 6.03% | 8,436,179 | $35.01M | Institution |
| Shah Capital Management | 5.56% | 7,780,756 | $32.29M | Institution |
| Morgan Stanley | 5.17% | 7,241,455 | $30.05M | Institution |
| James B. 1. Tananbaum | 4.48% | 6,268,455 | $26.01M | Insider |
| Sj Strategic Investments LLC | 2.86% | 4,001,500 | $16.61M | Insider |
| Thomas P. Monath | 2.31% | 3,232,366 | $13.41M | Insider |
| Rajiv I. Modi | 1.79% | 2,500,000 | $10.38M | Insider |
NVAX vs Biotech Stocks
Novavax Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.